Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation

Mesenchymal‐epithelial transition (MET) pathway activation is associated with the mechanisms that influence properties affecting cancer cell survival and invasiveness. The MET exon 14 skipping mutation (METex14del) is found in 2%–3% of patients with non‐small cell lung cancer (NSCLC). Previous studi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thorac Cancer
Main Authors: Takamori, Shinkichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Toyozawa, Ryo, Seto, Takashi, Yamaguchi, Masafumi, Okamoto, Tatsuro
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons Australia, Ltd 2021
Teme:
Case Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952779/
https://ncbi.nlm.nih.gov/pubmed/33533182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13871
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki